Turbine
PrivateLast Round
Series B
Feb 24, 2026
Total Funding Raised
$83.22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Turbine operates in Healthcare & Life Sciences and is based in Budapest. Its latest recorded funding round was a Series B round in February 2026.
Turbine is a biotechnology company that develops AI-driven cell simulation software to accelerate drug discovery and improve clinical translatability for oncology and immunology research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Turbine Comparables
Compare Turbine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytoReason | 84% | |
| Aitia | 81% | |
| DeepLife | 79% |
For institutional investors. Book with your work email.
Turbine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 24, 2026 | ||||
| Corporate Funding | May 16, 2024 | ||||
| Series A | Jun 20, 2023 | ||||
| Series A | Nov 22, 2022 | ||||
| Pre Seed | Jan 7, 2021 | ||||
Seed | Jan 9, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Turbine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Global Health Innovation Fund | Series B, Series A |
| Interactive Venture Partners | Series B |
| Day One Capital | Series A |
| o2h ventures | Series A, Pre Seed, Seed |
| Accenture Ventures | Corporate Funding |
| Boston Millennia Partners | Series A, Pre Seed |
| Atlantic Labs | Pre Seed, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Raised $25M led by Interactive Venture Partners.
- Aug 4, 2025
Will simulate hard-to-treat cancer patient populations.
For institutional investors. Book with your work email.
Turbine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Turbine's valuation, stock price, and market status.
Is Turbine a public or private company?
Turbine is a private company.
What is the current stock price of Turbine?
Turbine is a private company, so its shares have no public market price. Caplight tracks Turbine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Turbine worth (valuation)?
Valuation information for Turbine is not publicly available.
Can I buy Turbine stock?
Turbine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Turbine's last funding round?
Turbine's most recent funding round was Series B on February 24, 2026.
Who are the main investors in Turbine?
Key investors in Turbine include Interactive Venture Partners, Accenture Ventures, MassMutual Ventures, Delin Ventures, Mercia Ventures.
Will Turbine IPO soon?
No public IPO plans have been announced for Turbine.
How can I track Turbine secondary market activity?
Caplight tracks bids, offers, and trades in Turbine's shares on secondary markets.